fexofenadine (Allegra)

10/01/1999 - "Once-daily fexofenadine HCl, 120 or 180 mg, significantly improved patient-reported quality of life and reduced performance impairment in work and daily activities due to seasonal allergic rhinitis symptoms compared with placebo."
11/01/1997 - "Fexofenadine HCl is both effective and safe for the treatment of ragweed seasonal allergic rhinitis. "
01/01/2011 - "Systematic review on the efficacy of fexofenadine in seasonal allergic rhinitis: a meta-analysis of randomized, double-blind, placebo-controlled clinical trials."
06/01/2004 - "To evaluate the safety and efficacy of fexofenadine in children with seasonal allergic rhinitis, data were pooled from three, double-blind, randomized, placebo-controlled, parallel-group, 2-week trials in children (6-11 year) with seasonal allergic rhinitis. "
06/01/2004 - "Safety and efficacy of oral fexofenadine in children with seasonal allergic rhinitis--a pooled analysis of three studies."

02/01/1998 - "Fexofenadine 180 or 240mg once daily was significantly more effective than placebo in patients with chronic idiopathic urticaria. "
09/19/2008 - "These studies also support the contention that fexofenadine is effective for the treatment of allergic rhinits and chronic idiopathic urticaria."
02/01/2000 - "Although no comparative data with other H1 antagonists exist, fexofenadine 180 mg once daily was effective in reducing the symptoms of chronic idiopathic urticaria for up to 6 weeks. "
05/01/2000 - "Fexofenadine HCl is safe and effective for treatment of chronic idiopathic urticaria."
04/01/2020 - "The primary purpose of this study is to find out the efficacy of fexofenadine in the treatment of chronic idiopathic urticaria patients among the Bangladeshi population. "

04/01/2021 - "Fexofenadine HCl 180 mg was effective in relieving pollen-induced, air pollution-aggravated allergic rhinitis symptoms."
12/01/2005 - "Fexofenadine 30 mg bid is effective in reducing the total symptom score of allergic rhinitis including blocked nose and is generally well tolerated. "
10/01/2005 - "Fexofenadine is effective for the treatment of allergic rhinitis. "
12/01/2002 - "Clinical studies have documented the efficacy of fexofenadine in the treatment of allergic rhinitis. "
07/01/2023 - "Double blind, placebo controlled, randomized clinical trials investigating the efficacy and safety of fexofenadine for the treatment of Allergic Rhinitis were searched in 5 major global databases. "

02/01/2006 - "Our results suggest that fexofenadine can be beneficial in the daily management of patients with itching due to eczematous disease."
06/01/2005 - "Patients administered fexofenadine (n = 163) experienced significantly greater improvements in MNW and pruritus severity scores compared with the placebo group (n = 92) (P < .001 for both). "
06/01/2003 - "Compared with placebo, fexofenadine significantly improved both diurnal (P = 0.0001) and nocturnal pruritus (P = 0.013). "
06/01/2003 - "Fexofenadine (n = 201) significantly decreased the severity of pruritus compared with placebo (n = 199) (mean change in score -0.75 (unadjusted 95% confidence interval [-0.88, -0.62]) vs. -0.5 [-0.62, -0.38], respectively; P = 0.0005). "
11/01/1999 - "Two subjects developed mild itching, which cleared up after receiving Allegra; the third subject did not respond to the treatment."

11/01/2012 - "Those with significant improvement of urticaria activity score under fexofenadine at 180 mg were included in the CIU group. "
05/13/2022 - "The present narrative review provides a comprehensive update of the current knowledge on urticaria, both in adult and pediatric populations, and on the safety and efficacy of fexofenadine hydrochloride (HCl) as a treatment option. "
03/01/2002 - "Evaluation of the efficacy and safety of fexofenadine in the management of chronic idiopathic urticaria: a prospective study with 512 patients."
07/23/2022 - "Correction to: Insights into urticaria in pediatric and adult populations and its management with fexofenadine hydrochloride."
05/13/2022 - "Herein, the efficacy and safety of fexofenadine HCl, a representative second-generation H1-antihistamine approved for the treatment of urticaria, is discussed. "